(Q62030974)

English

Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus

clinical trial

Statements

Impact of Chronic Kidney Disease (CKD) on Pharmacodynamic Profiles of the P2Y12 Receptor Inhibitor Clopidogrel in the Setting of Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD) (English)
0 references
January 2019
0 references
January 2020
0 references
60
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit